
Aristo Pharma lanza Levosulpirida Aristo EFG
noviembre 12, 2020 12:10 pmEn presentaciones de 25 mg en formatos de 30 y 60 comprimidos, indicado contra las náuseas y los vómitos
En presentaciones de 25 mg en formatos de 30 y 60 comprimidos, indicado contra las náuseas y los vómitos
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.